Search

Search Results
Results 18591 - 18600 of 18646 for stroke
  • Anpec (new formulation)
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Anpec (new formulation) intended for persons living in Australia.
  • Celsentri
    Drug - 11 Nov 2022
    Consumer Medicine Information (CMI) about Celsentri intended for persons living in Australia.
  • Minitran
    Drug - 6 Nov 2022
    Consumer Medicine Information (CMI) about Minitran intended for persons living in Australia.
  • Co-Diovan
    Drug - 1 Nov 2022
    Consumer Medicine Information (CMI) about Co-Diovan (Valsartan/hydrochlorothiazide) intended for persons living in Australia.
  • Agrylin
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Agrylin intended for persons living in Australia.
  • Accupril
    Drug - 2 Sep 2022
    Consumer Medicine Information (CMI) about Accupril intended for persons living in Australia.
  • Adenoscan
    Drug - 31 Aug 2022
    Consumer Medicine Information (CMI) about Adenoscan intended for persons living in Australia.
  • Adenocor
    Drug - 31 Aug 2022
    Consumer Medicine Information (CMI) about Adenocor intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Accuretic
    Drug - 27 Jul 2022
    Consumer Medicine Information (CMI) about Accuretic intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback